Pyrrolopyridine-aniline compounds for treatment of dermal disorders
US11161845B2 · kind B2 · utility
6Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 2018 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Jun 9, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating diseases or disorders in a subject where the subject is in need of an inhibitor of MEK where the Compound is according to Formula (I), where X1, R1, R2, R2a, R3, R3a, and R3b are as described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.